Trial Profile
COVID-19 Ring-based Prevention Trial With Lopinavir/Ritonavir
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2023
Price :
$35
*
At a glance
- Drugs Lopinavir/ritonavir (Primary)
- Indications SARS-CoV-2 acute respiratory disease
- Focus Therapeutic Use
- Acronyms CORIPREV-LR
- 29 Nov 2021 Status changed from recruiting to active, no longer recruiting.
- 22 Mar 2021 Trial design, published in the Trials
- 17 Apr 2020 Status changed from not yet recruiting to recruiting.